Beauty giants target ‘Ozempic face’ as boom in obesity drugs opens new market | Consumer
By Richa Naidu, Dominique Patton and Alexander Marrow LONDON/PARIS, Oct 21 (Reuters) – Swiss skincare firm Galderma, Brazilian…
‘Die with zero’ gains momentum. How to turn it into a financial plan | Consumer
“Die With Zero” has caught on to encourage retirees to spend to their hearts’ delight rather than scrimping,…
Is Social Security broke? 6 big retirement misconceptions | Consumer
Retirement myths abound. Many Americans harbor basic misconceptions about Social Security, Medicare and other pillars of retirement. Here…
The ‘magic number’ for a comfortable retirement just got bigger | Consumer
Retirement planners sometimes speak of a “magic number”: a rough estimate of how much money an American might…
Planning to work in retirement? Don’t count on it. | Consumer
Most Americans plan to keep on working after they retire. Yet, few retirees work. That finding, from a…
The GLP-1 weight loss side effect that isn’t talked about | Consumer
Over the past five years, Samantha Milton lost 260 pounds − and about 12 of those pounds were…
Patients claim blindness, bowel injuries from GLP-1 drugs | Consumer
A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then…
Why Apple is pushing the iOS 26.2.1 update | Consumer
iPhone users likely received a recent notification about the latest update: iOS 26.2.1. Available on eligible devices immediately,…
Renoir’s drawings showcased in major exhibition, the first of its kind in over a century | News
New York (CNN) — Pierre-Auguste Renoir was one of the leaders of the Impressionist school of painting, established…